Tularemia: Pathogenesis and Host Response
兔热病:发病机制和宿主反应
基本信息
- 批准号:7255387
- 负责人:
- 金额:$ 118.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-08 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Francisella tularensis can cause serious illness and death in humans. F. tularensis is considered to be one of the most likely bioweapons due to ease of dissemination through aerosolization, and the high morbidity and mortality associated with inhalation tularemia. There is currently no tularemia vaccine licensed for general use, and thus human populations are at significant risk from the illicit use of F. tularensis. Very little is known about F. tularensis pathogenesis and host response, and thus fundamental research into F. tularensis biology is critical for the future development of therapeutics and vaccines against tularemia. We have assembled a group of integrated research projects focused on Francisella pathogenesis and immunity from researchers at the University of Texas San Antonio and the University of Texas Health Science Center in San Antonio. The individual projects are designed to be highly integrated with the other projects, and ultimately lead to a synergy that will propel our knowledge of this potential bioweapon such that new antimicrobial strategies can be developed. Virtually nothing is known about aerosol infections of F. tularensis subsp. tularensis (Type A), the most likely bioweapon form of tularemia, and thus this program project focuses almost exclusively on this form of tularemia. Our integrated bacteriological and immunological research approach involves four research projects and three support cores. These projects are designed to 1. identify essential and virulence factors of F. tularensis, 2. detail the immunology of inhalation tularemia in situ, 3. characterize the role of Toll-like receptors in host response, and 4. identify T cell epitopes and characterize T cell mediated responses to F. tularensis. These projects will be supported by an administrative core, a genomics core, and an immunomicroscopy core. The collaborative interactions of the investigators will ultimately lead to a dramatic increase in our understanding of pathogen-host interactions during F. tularensis subsp. tularensis aerosol infections, and facilitate the development of novel therapeutics and vaccines to combat weaponized tularemia.
描述(由申请人提供):土拉热弗朗西斯菌可导致人类严重疾病和死亡。F.土拉菌病被认为是最有可能的生物武器之一,因为它易于通过雾化传播,而且与吸入性土拉菌病相关的发病率和死亡率很高。目前还没有许可用于一般用途的兔热病疫苗,因此人类群体面临着非法使用F.土拉热。关于F的知之甚少。土拉热菌的致病机理和宿主反应,从而为土拉热菌的基础研究奠定了基础。土拉菌生物学对于未来开发抗土拉菌病的治疗剂和疫苗至关重要。我们已经从德克萨斯大学圣安东尼奥和德克萨斯大学圣安东尼奥健康科学中心的研究人员那里收集了一组集中于弗朗西斯菌发病机制和免疫的综合研究项目。各个项目被设计成与其他项目高度整合,并最终导致协同作用,这将推动我们对这种潜在生物武器的了解,从而可以开发新的抗菌策略。事实上,对F.土拉热亚种土拉热病(A型),最有可能的生物武器形式的土拉热病,因此,本方案项目几乎完全侧重于这种形式的土拉热病。我们的综合细菌学和免疫学研究方法涉及四个研究项目和三个支持核心。这些项目旨在1。鉴定F. tularensis,2.详细介绍了吸入性兔热病的免疫学特点,3.表征Toll样受体在宿主应答中的作用,和4.鉴定T细胞表位和表征T细胞介导的对F.土拉热。这些项目将得到一个行政核心、一个基因组学核心和一个免疫显微镜核心的支持。研究人员的协作互动最终将大大提高我们对F.土拉热亚种土拉菌气溶胶感染,并促进对抗武器化土拉菌病的新型疗法和疫苗的开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karl E Klose其他文献
Karl E Klose的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karl E Klose', 18)}}的其他基金
F. tularensis Virulence Protein Structure and Function
F. tularensis 毒力蛋白结构和功能
- 批准号:
7433908 - 财政年份:2007
- 资助金额:
$ 118.16万 - 项目类别:
F. tularensis Virulence Protein Structure and Function
F. tularensis 毒力蛋白结构和功能
- 批准号:
7314377 - 财政年份:2007
- 资助金额:
$ 118.16万 - 项目类别:
Characterization of F. tularensis Virulence Genes
土拉弗朗西斯毒力基因的表征
- 批准号:
6912409 - 财政年份:2005
- 资助金额:
$ 118.16万 - 项目类别:
相似海外基金
The evolution of host-flavivirus interactions and their impact on viral pathogenesis and host response
宿主-黄病毒相互作用的演变及其对病毒发病机制和宿主反应的影响
- 批准号:
477179 - 财政年份:2023
- 资助金额:
$ 118.16万 - 项目类别:
Operating Grants
Defining the changing microbiome composition and host-microbe mechanistic effects following Apc inactivation during colorectal cancer pathogenesis
定义结直肠癌发病过程中 Apc 失活后微生物组组成的变化和宿主微生物机制效应
- 批准号:
10750676 - 财政年份:2023
- 资助金额:
$ 118.16万 - 项目类别:
Pathogenesis, immunity, and control of coronaviruses in a large natural host animal, the pig
大型自然宿主动物猪中冠状病毒的发病机制、免疫和控制
- 批准号:
BB/X014266/1 - 财政年份:2023
- 资助金额:
$ 118.16万 - 项目类别:
Research Grant
Impact of host responses on mpox pathogenesis and tecovirimat efficacy in the Collaborative Cross mouse model of genetic diversity
遗传多样性协作交叉小鼠模型中宿主反应对 MPOX 发病机制和 tecovirimat 功效的影响
- 批准号:
481136 - 财政年份:2023
- 资助金额:
$ 118.16万 - 项目类别:
Operating Grants
Mechanisms of visceral leishmaniasis pathogenesis and implications for host-directed therapy development
内脏利什曼病发病机制及其对宿主导向治疗开发的影响
- 批准号:
478479 - 财政年份:2023
- 资助金额:
$ 118.16万 - 项目类别:
Operating Grants
CSHL 2023 Conference on Microbial Pathogenesis & Host Response
CSHL 2023微生物发病机制会议
- 批准号:
10675902 - 财政年份:2023
- 资助金额:
$ 118.16万 - 项目类别:
Pathogenesis of and host response to chikungunya virus infection of the central nervous system
中枢神经系统基孔肯雅病毒感染的发病机制和宿主反应
- 批准号:
10764851 - 财政年份:2023
- 资助金额:
$ 118.16万 - 项目类别:
Understanding how motors drive the pathogenesis in host cells infected with Chlamydia trachomatis.
了解马达如何驱动感染沙眼衣原体的宿主细胞的发病机制。
- 批准号:
491115 - 财政年份:2023
- 资助金额:
$ 118.16万 - 项目类别:
Fellowship Programs
Orientia tsutsugamushi Ank-host interactions in scrub typhus pathogenesis
恙虫病东方体在恙虫病发病机制中的Ank-宿主相互作用
- 批准号:
10413474 - 财政年份:2022
- 资助金额:
$ 118.16万 - 项目类别:
Virulent Rickettsia species utilize the CD300f phosphatidylserine-binding receptor on macrophages for host colonization and pathogenesis
强毒立克次体利用巨噬细胞上的 CD300f 磷脂酰丝氨酸结合受体进行宿主定植和发病机制
- 批准号:
10526450 - 财政年份:2022
- 资助金额:
$ 118.16万 - 项目类别: